AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 359.44 | 295.80 | 241.93 | 217.87 | 151.01 |
| Loan funds | |||||
| Secured loans | - | - | - | - | - |
| Unsecured loans | - | - | - | - | - |
| Total | 364.44 | 300.80 | 246.93 | 222.87 | 156.01 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 132.84 | 119.83 | 105.85 | 102.57 | 200.75 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 61.31 | 45.00 | 30.39 | 15.73 | 103.40 |
| Net block | 71.53 | 74.83 | 75.46 | 86.84 | 97.36 |
| Capital work-in-progress | 24.24 | 6.90 | 3.57 | 4.81 | 6.31 |
| Investments | - | - | - | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 610.59 | 480.07 | 381.51 | 323.84 | 302.05 |
| Less : current liabilities & provisions | 341.92 | 261.00 | 213.61 | 192.62 | 249.71 |
| Total net current assets | 268.67 | 219.07 | 167.90 | 131.22 | 52.35 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 364.44 | 300.80 | 246.93 | 222.87 | 156.01 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | 0.01 |
| Contingent liabilities | 69.19 | 32.57 | 11.85 | 17.25 | 42.75 |
| Number of equity sharesoutstanding (Lacs) | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis